| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8630128 | Diabetes Research and Clinical Practice | 2018 | 28 Pages |
Abstract
The current study lends supports for the development of SGLT2 inhibitors in combination with insulin as a treatment option for patients with type 1 diabetes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Dana El Masri, Samiran Ghosh, Linda A. Jaber,